Month: June 2020

Ashvattha Therapeutics Subsidiary Orpheris Announces Completion of Phase 1 Study of OP-101 Subcutaneous Formulation

November 12, 2020June 10, 2020 by ashvatthaadmin

Orpheris, a subsidiary of Ashvattha, announced results from a Phase 1 single administration study evaluating the subcutaneous (SC) formulation of OP-101 (4 or 8 mg/kg) in healthy volunteers.

Categories Press Release

Search for:

Howdy, this is Creativo

We just added a brand new Off Canvas Sidebar. You can change the content you see here by going to Appearance -> Widgets -> Off Canvas Sidebar.

Of course you can also change the design of this sidebar by going to Appearance -> Theme Options -> Off Canvas Sidebar.

Change everything from: background color, font color, font size, sidebar headings and more.